Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
INCB099280 for Skin Cancer
Recruiting1 awardPhase 2
Las Vegas, Nevada
This trial is testing a new drug called INCB099280 to see if it is safe and works well for people with advanced skin cancer. The drug aims to stop the cancer cells from growing by blocking certain signals.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service